News | February 11, 2021
Sun Pharma Advanced Research Q3FY21 loss at Rs. 67.62 crore
The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.
The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.
The company posted net profit of Rs.62.17 crores for the period ended December 31, 2019.
The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.
The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.
The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020.
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
The company is expecting tremendous growth and a better quarterly performance
Strides Pharma Science Limited is pleased to announce that Aditya Puri joins the Strides Group as an Advisor and also will be a Director of its associate Company, Stelis Biopharma.
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated
